AQSTNasdaq United States
Market cap
$494.340 M
$3.94 +0.51%
Close of 7 Aug 2026
Revenue
$44.5M
#2780 by revenue
Earnings
-$83.8M
Loss-making
Shares outstanding
122,045,049
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Aquestive Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.